Jyothy Labs Ltd. share price target

We maintain our HOLD rating on the stock and revise our TP to Rs 280/share. The TP implies an upside potential of 4% from the CMP.

Jyothy Labs’ (JYL) Q4FY26 performance reflects a robust, volume-led recovery, validating management's strategy to defend and expand market share.

...

We revise our rating to HOLD from BUY.

...

ease and festive demand kicks in. Margin trajectory should improve in H2FY26, supported by stable commodity prices, normalization of pricing actions, and scaling of premium launches. The company's innovation pipeline, including Dr. Wool and Ujala Young & Fresh, along with strong...

JYL’s Q2FY26 performance was impacted by GST-led disruption and pricing/grammage adjustments (value/volume growth of 0.4%/2.8% YoY).

Considering the near-term challenges, we maintain our HOLD rating on the stock and revise our TP to Rs 320/share. The TP implies an upside potential of 3% from the CMP.

Jyothy Laboratories (JYL) posted flat YoY sales growth in 2QFY26, with volumes rising 3% (est. 4%; 1QFY26 4%). The difference between value and volume growth was primarily due to MRP reductions, higher grammage, and promotional price-offs in select categories.

JLL delivered a modest Q1FY26 performance amid a challenging demand environ- Gross margin contracted 280bps YoY to 48.5%, due to input cost pressures and heightened competition in the Dish wash segment. EBITDA margin stood at 16.5%,...

Considering the near-term challenges, we have downgraded the stock from BUY to HOLD and revised our TP to Rs 355/share, implying an upside potential of 7% from the CMP.

JYL’s Q1FY26 performance was subdued with revenue/ volume growth of 1.4%/ 3.6% YoY impacted by heightened competitive intensity across segments.

Q4FY25 was yet another muted quarter for JLL amid subdued demand and higher competitive intensity hit revenue growth, while inflation in key input prices impacted profitability.

Jyothy Laboratories (JYL) reported 1% YoY sales growth (below our est.) in 4QFY25. Volume growth was 4% (est. 7%, 8% in 3QFY25). The gap between volume and value growth was due to higher grammage and promotional price subs in select categories.

We recommend a BUY with a near-term TP of Rs 405, implying an upside of 10% from the CMP.

With a 13% upside from the CMP, we maintain our long-term BUY rating on the stock.